Research delves into impulsive behaviors in Parkinsonian rats, linking them to striatal activity under pharmacological interventions.Study reveals complexities of impulsive-compulsive behaviors in response to dopamine receptor agonists and L-DOPA therapy.Implications extend to balancing motor symptom relief with behavioral stability in Parkinson’s disease management.Striatum’s pivotal role in Parkinson’s pathology is highlighted, showcasing the impact of dopamine depletion on movement and behavior regulation.D2/3 agonists and L-DOPA exhibit divergent effects on striatal neuroactivity, accentuating the intricate interplay between treatment modalities.Distinct mechanisms through receptor-specific actions emphasize the challenge in optimizing therapeutic outcomes while minimizing side effects.Neural circuitry alterations induced by dopaminergic signaling shed light on the dual nature of treatment effects in Parkinson’s patients.Integral role of selective dopamine receptor targeting in influencing behavioral outcomes is underscored for tailored therapeutic interventions.Study underscores the need for personalized care, early detection, and precise treatment strategies in neurodegenerative diseases like Parkinson’s.The integration of multidisciplinary approaches in Parkinson’s research is advocated to address the complexity of the disorder.